Stock market news live updates: Futures mixed after 4-day rout, COVID surge weighs
The broader market is coming off a 4-day losing streak, as investors get more jittery about COVID-19’s economic impact.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte Biosciences, Inc. – FBRX
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Forte…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 20, 2021 deadline to file a lead…
The Best Places in Every State To Live on a Fixed Income
The average Social Security benefit for retired workers in 2021 is $1,548 per month. That comes out to $18,576…
Curaleaf Announces Voting Results of its Annual and Special Meeting of Shareholders
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer…
Clarivate Announces Secondary Ordinary Share Offering
Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”) announced today that affiliated funds of Onex Corporation (“Onex”)…
Brompton Proposes Conversion of Flaherty & Crumrine Investment Grade Preferred Income Fund Into an Exchange Traded Fund
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — (TSX: FFI.UN) Brompton Funds Limited (“Brompton” or the “Manager”), the manager of…
Ovintiv Announces Increasing Shareholder Returns with New Capital Allocation Framework
Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced a new capital allocation framework, which supports the Company’s goal of…
Portage Fintech Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 10, 2021
Portage Fintech Acquisition Corporation (Nasdaq: PFTAU) (the “Company”) today announced that, commencing September 10, 2021,…
Regulus Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative…
recent post
-
Sep 10 2025 -
Sep 10 2025
-
Sep 10 2025
-
Sep 10 2025
-
